Obstacles to trials of chronic Lyme disease in actual practice

Minerva Medica

Volumn 100, Issue 5, 2009, Pages 435-436

  Cameron, D ^a  

^a Northern Westchester Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; ARTHRALGIA; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL STUDY; FATIGUE; HEART DISEASE; LETTER; LYME DISEASE; METHODOLOGY; NEUROLOGIC DISEASE; QUALITY OF LIFE;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; HUMANS; LYME DISEASE; PATIENT DROPOUTS; PATIENT SELECTION; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77949534748     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Wormser GP, Shapiro ED, Halperin JJ, Porwancher RB, O'Connell S, Nadelman RB et al. Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatment. Minerva Med 2009;100:171-2.
2. Cameron D. Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial. Minerva Med 2008;99:489-96.
3. Asch ES, Bujak DI, Weiss M, Peterson MG, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 1994;21:454-61.
4. Cameron DJ. Clinical trials validate the severity of persistent Lyme disease symptoms. Med Hypotheses 2008;72:153-6.
5. Cameron DJ. Generalizability in two clinical trials of Lyme disease. Epidemiol Perspect Innov 2006;3: 12.
6. Cameron DJ. Insufficient evidence to deny antibiotic coverage to chronic Lyme disease patients. Med Hypotheses 2009;72:688-91.